Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower vitamin D levels than healthy people.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Many research paper titles in dermatology journals lack scientific precision.

A machine learning model can predict alopecia areata early using specific gene markers.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Combining ultrasound and microneedles improves drug delivery through the skin.

Biologics for severe asthma have known side effects, but some new risks need more study.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

New cytokine-targeted therapies show promise for treating alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Fetal skin has unique immune cells different from adult skin.

Azathioprine may help treat severe alopecia areata, but more research is needed.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

A new treatment plan for alopecia areata considers disease severity, quality of life, and progression to offer personalized care.

Current treatments for keratosis pilaris provide temporary relief, but more research is needed for better solutions.

Understanding tissue remodeling can help create precise treatments for various organ issues.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

A newborn with ichthyosis was successfully treated using specific neonatal care methods.

Polynucleotide-based treatments effectively reduce aging signs and aid tissue recovery.